Related Experiment Video
Updated: Mar 30, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical course
I Pezzini1, A Geroldi1, S Capponi1
1Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal-Infantile Sciences (DINOGMI), Medical Genetics, University of Genoa, Viale Benedetto XV, 16132, Genoa, Italy.
Dominant mutations in the ganglioside-induced differentiation associated-protein 1 (GDAP1) gene are a frequent cause of Charcot-Marie-Tooth (CMT) axonal neuropathy in Italy. Analyzing GDAP1 early is recommended for Italian CMT2 patients.
Area of Science:
- Genetics
- Neurology
Background:
- Mutations in the ganglioside-induced differentiation associated-protein 1 (GDAP1) gene are linked to Charcot-Marie-Tooth (CMT) axonal neuropathy, presenting in both autosomal recessive (AR) and dominant (AD) forms.
- The prevalence of heterozygous, dominant GDAP1 mutations in the Italian CMT population remains uncharacterized.
Purpose of the Study:
- To determine the frequency of dominant GDAP1 mutations in Italian patients with axonal CMT.
- To explore the correlation between these mutations and clinical manifestations.
Main Methods:
- Genomic DNA sequencing and copy number variation analysis were performed on 109 Italian axonal CMT patients.
- All patients had previously been tested for common axonal AD genes.
Main Results:
- Heterozygous mutations in GDAP1 were identified in eight patients (7.3%), harboring five previously reported mutations.
- The relative frequency of GDAP1 mutations (7.3%) exceeded that of MFN2 (6.3%) and MPZ (5.0%) in this cohort.
- Observed mutations exhibited variable penetrance, with symptom onset in the first decade and a slower progression compared to AR-CMT.
Conclusions:
- Dominant GDAP1 mutations are a significant cause of axonal CMT in Italy, with a frequency higher than MFN2 and MPZ.
- The milder clinical features and indolent course associated with these mutations are important for prognostic assessments.
- GDAP1 should be considered the primary gene for analysis in Italian patients diagnosed with CMT2.
More Related Videos
06:49A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
06:02Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
Published on: November 28, 2025